HDAC1/3-IN-1
Based on 1 Customer Validation
HDAC1/3-IN-1 is a selective HDAC1/3 inhibitor, with IC50 values of 256 nM and 340.3 nM against HDAC1 and HDAC3, respectively. HDAC1/3-IN-1 increases the SubG1 cell population and promotes apoptosis of glioma cells and glioblastoma stem cells. HDAC1/3-IN-1 can be used in studies related to glioblastoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.81%
- CAS No.: 244289-53-0
- Formule: C19H17N3O3S
- Masse moléculaire:367.42
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Activité biologique
Description
IC50 & Target
[1]|
HDAC1 256 nM (IC50) |
HDAC3 340.3 nM (IC50) |
In Vitro
HDAC1/3-IN-1 (Compound 6a) (0.6-50 μM; 24-72 h) inhibits the proliferation of HOG, T98G, U87MG and U251MG glioma cell lines in a time-dependent manner, with the lowest GI50 of 0.6 μM measured in U251MG cells after 72 h of incubation[1].
HDAC1/3-IN-1 (10.8-50 μM; 24 h) inhibits histone H3 deacetylation in HOG, T98G and U251MG glioma cell lines when applied at the relevant concentrations for 24 h[1].
HDAC1/3-IN-1 (10.8-50 μM; 24 h) induces SubG1 phase cell accumulation in aggressive glioma cell lines T98G and U251MG, suggesting the presence of DNA fragmentation and apoptosis, while also modulating the cell cycle phase distribution of the tested glioma cell lines[1].
HDAC1/3-IN-1 (10.8-50 μM; 24 h) induces early apoptosis in glioma cell lines HOG, T98G, U87MG and U251MG[1].
HDAC1/3-IN-1 (72 h) inhibits the viability of mesenchymal (GG16) and proneural (GSC23) glioblastoma stem cell lines, with IC50 values of 2.079 μM and 1.851 μM respectively after 72 h of incubation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Glioma cell lines HOG, T98G, U87MG, U251MG
-
Concentration:50 μM (HOG, T98G, U87MG); 10.8 μM (U251MG)
-
Incubation Time:24 h
-
Result:Promoted accumulation of acetyl-histone H3 in HOG, T98G, and U251MG cell lines, with comparable effects to positive controls in these cells.
-
Cell Line:Glioma cell lines HOG, T98G, U87MG, U251MG
-
Concentration:50 μM (T98G); 10.8 μM (U251MG)
-
Incubation Time:24 h
-
Result:Increased the percentage of cells in the SubG1 phase in T98G and U251MG cell lines.
Modulated cell cycle phase distribution, increasing the G0/G1 phase in HOG cells and modulating the S phase in U87MG cells.
-
Cell Line:Glioma cell lines HOG, T98G, U87MG, U251MG
-
Concentration:50 μM (HOG, T98G, U87MG); 10.8 μM (U251MG)
-
Incubation Time:24 h
-
Result:Induced early apoptosis in HOG, T98G, U87MG, and U251MG cell lines.
Chemical Information
-
CAS No. 244289-53-0
-
Appearance Solid
-
Masse moléculaire 367.42
-
Formule C19H17N3O3S
-
Color White to off-white
-
SMILES
O=C(NC1=CC=CC=C1N)C2=CC=C(NS(=O)(C3=CC=CC=C3)=O)C=C2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
In Vitro:
DMSO : 50 mg/mL (136.08 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocole
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Pureté et documentation
-
Fiche technique (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.7217 mL | 13.6084 mL | 27.2168 mL | 68.0420 mL |
| 5 mM | 0.5443 mL | 2.7217 mL | 5.4434 mL | 13.6084 mL | |
| 10 mM | 0.2722 mL | 1.3608 mL | 2.7217 mL | 6.8042 mL | |
| 15 mM | 0.1814 mL | 0.9072 mL | 1.8145 mL | 4.5361 mL | |
| 20 mM | 0.1361 mL | 0.6804 mL | 1.3608 mL | 3.4021 mL | |
| 25 mM | 0.1089 mL | 0.5443 mL | 1.0887 mL | 2.7217 mL | |
| 30 mM | 0.0907 mL | 0.4536 mL | 0.9072 mL | 2.2681 mL | |
| 40 mM | 0.0680 mL | 0.3402 mL | 0.6804 mL | 1.7011 mL | |
| 50 mM | 0.0544 mL | 0.2722 mL | 0.5443 mL | 1.3608 mL | |
| 60 mM | 0.0454 mL | 0.2268 mL | 0.4536 mL | 1.1340 mL | |
| 80 mM | 0.0340 mL | 0.1701 mL | 0.3402 mL | 0.8505 mL | |
| 100 mM | 0.0272 mL | 0.1361 mL | 0.2722 mL | 0.6804 mL |